Litcius/Paper detail

Cardiovascular and Renal Benefit of Novel Non-steroidal Mineralocorticoid Antagonists in Patients with Diabetes

Ulrich Kintscher

2023Current Cardiology Reports11 citationsDOI

Topics & Concepts

MedicineMRASKidney diseaseMineralocorticoid receptorEplerenoneHeart failureClinical trialDiseaseInternal medicineAdverse effectPharmacologySpironolactoneIntensive care medicineAldosteroneInduction motorVoltageQuantum mechanicsVector controlPhysicsHormonal Regulation and HypertensionElectrolyte and hormonal disordersCardiovascular, Neuropeptides, and Oxidative Stress Research
Cardiovascular and Renal Benefit of Novel Non-steroidal Mineralocorticoid Antagonists in Patients with Diabetes | Litcius